CEOs’ Fireside Chat

Time: 11:00 am
day: Pre-Conference Day AM


With the next wave of mRNA medicines approaching, and companies who were involved pre- pandemic now utilising

validated platforms to develop new therapeutics and vaccines, this leads to the inevitable question: What comes next?

We now need to realise the opportunities of such mRNA- based therapeutic applications, as we hear from the leaders of the field on the future of this technology.

  • What does the future look like for the next generation of mRNA- based therapeutics for clinically relevant targets?
  • Where do we expect new innovations to come from, and what challenges lie ahead of us?
  • What limits actual development, where mRNA could be leveraged to replace existing technologies?